Epilepsy Pathway Innovation in Africa
Epilepsy affects over 50 million people across the world. 80% of these people live in low to middle income countries. There is a very high rate of epilepsy in Africa, where misunderstanding and stigma lead to limited diagnoses and treatment.
Epilepsy Pathway Innovation in Africa (EPINA) is a research team based in Oxford that has partnered with leading institutions in Kenya, Ghana and Tanzania. Working in these countries, EPINA aims to:
- better understand the impact of stigma on people with epilepsy
- improve epilepsy knowledge to improve help-seeking and treatment
- develop an app to help healthcare workers to diagnose epilepsy
- develop portable electroencephalograms to diagnose epilepsy in rural settings
- improve medication adherence through text messaging.
EPINA could dramatically change the lives of people with epilepsy in sub Saharan Africa. If successful, we will use our knowledge to ensure that similar work is carried out across other low and middle-income countries.
Visit the EPInA website here: https://epina.web.ox.ac.uk
Subscribe to the EPInA newsletter here: https://epina.web.ox.ac.uk/article/newsletters
Latest publications
-
Domain-specific cognitive impairments, mood and quality of life 6 months after stroke
Journal article
Milosevich E. et al, (2024), Disability and Rehabilitation, 1 - 10
-
Automated quality control of T1-weighted brain MRI scans for clinical research: methods comparison and design of a quality prediction classifier
Preprint
Bhalerao GV. et al, (2024)
-
Rebound activation of 5-HT neurons following SSRI discontinuation.
Journal article
Collins HM. et al, (2024), Neuropsychopharmacology
-
Development of an enhanced scoring system to predict ICU readmission or in-hospital death within 24 hours using routine patient data from two NHS Foundation Trusts.
Journal article
Pimentel MAF. et al, (2024), BMJ Open, 14